Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Virtual EASL 2021: Rapid Audio Recap

June 23-26, 2021; Virtual
Hear insights from Stefan Zeuzem, MD, on exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.
Stefan Zeuzem, MD
Released: July 19, 2021

In this episode, Stefan Zeuzem, MD, discusses exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.

Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany

Acknowledgements

Educational grant provided by:
AbbVie
Antios Therapeutics
Gilead Sciences, Inc.

Related Content

Anna Christina L. dela Cruz, MD, and Clinical Care Options (CCO): Treating for hepatitis B despite laboratory values in the gray zone

Anna Christina L. dela Cruz, MD Released: July 28, 2021

Dr. Geoffrey Dusheiko, in conversation with Mark, who was diagnosed with hepatitis B after receiving immunomodulatory treatment for rheumatoid arthritis from Clinical Care Options (CCO)

Geoffrey M. Dusheiko, MD, FCP(SA), FRCP Released: July 26, 2021

From Clinical Care Options (CCO): Dr. Oluwaseun Falade-Nwulia and Dr. Joseph K. Lim on HCV disparities/barriers in Black, Hispanic, Asian, American Indian, Alaska Native persons

Released: July 22, 2021

Robert Gish on cure strategies at EASL 2021: si RNAs, JNJ-3989, AB-729, GSK3228836, VIR-3434, c-PAMs or capsid inhibitors, AB-836, and more from Clinical Care Options (CCO)

Robert G. Gish, MD Released: July 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue